Yuli Wang

1.9k total citations
51 papers, 1.4k citations indexed

About

Yuli Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuli Wang has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Yuli Wang's work include Cancer-related Molecular Pathways (6 papers), Ubiquitin and proteasome pathways (5 papers) and RNA Interference and Gene Delivery (4 papers). Yuli Wang is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Ubiquitin and proteasome pathways (5 papers) and RNA Interference and Gene Delivery (4 papers). Yuli Wang collaborates with scholars based in China, United States and South Korea. Yuli Wang's co-authors include Yunshan Wang, Guangwei Wei, Claudia Kent, Pengju Zhang, Nancy L. Allbritton, Jian‐Hua Mao, Chuanxin Wang, Lutao Du, Theodore S. Lawrence and Mingxin Wen and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Yuli Wang

49 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuli Wang China 22 1.0k 358 277 242 160 51 1.4k
Patrizia Perri Italy 24 817 0.8× 327 0.9× 376 1.4× 287 1.2× 185 1.2× 57 1.6k
Shaojun Zhu China 20 943 0.9× 326 0.9× 451 1.6× 196 0.8× 96 0.6× 47 1.6k
Hong Yao China 25 1.1k 1.0× 354 1.0× 466 1.7× 229 0.9× 152 0.9× 88 1.8k
Fei Lu China 25 1.5k 1.4× 334 0.9× 496 1.8× 243 1.0× 223 1.4× 96 2.2k
Fabio Cerignoli United States 22 1.1k 1.0× 293 0.8× 231 0.8× 144 0.6× 199 1.2× 30 1.6k
Jian Yu China 20 1.1k 1.1× 584 1.6× 281 1.0× 421 1.7× 149 0.9× 69 1.8k
Ranyi Liu China 22 767 0.7× 431 1.2× 411 1.5× 165 0.7× 119 0.7× 52 1.5k
Jan Olaf Stracke Switzerland 18 1.0k 1.0× 355 1.0× 351 1.3× 268 1.1× 150 0.9× 26 1.8k
Neveen Said United States 24 803 0.8× 491 1.4× 397 1.4× 343 1.4× 93 0.6× 36 1.8k
Jingjing Yu China 22 787 0.8× 367 1.0× 421 1.5× 273 1.1× 287 1.8× 82 1.6k

Countries citing papers authored by Yuli Wang

Since Specialization
Citations

This map shows the geographic impact of Yuli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuli Wang more than expected).

Fields of papers citing papers by Yuli Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuli Wang. The network helps show where Yuli Wang may publish in the future.

Co-authorship network of co-authors of Yuli Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuli Wang. A scholar is included among the top collaborators of Yuli Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuli Wang. Yuli Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Shouning, et al.. (2025). Exploring the mechanism of Bruceine D against cervical cancer by network pharmacology and the effect of Bruceine D on the EGFR pathway. Journal of Pharmaceutical and Biomedical Analysis. 262. 116887–116887. 1 indexed citations
2.
Gao, Sheng, et al.. (2025). Synergistic effects of fly ash-cement slurry and CO2 mineralization on coal gangue aggregate and its concrete properties. Construction and Building Materials. 465. 140225–140225. 8 indexed citations
5.
Feng, Maoxiao, Xiaodong Hao, Yidan Ren, et al.. (2023). Fatty Acids Support the Fitness and Functionality of Tumor-Resident CD8+ T Cells by Maintaining SCML4 Expression. Cancer Research. 83(20). 3368–3384. 14 indexed citations
6.
Bi, Lei, Yidan Ren, Maoxiao Feng, et al.. (2021). HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness. Cancer Research. 81(8). 2015–2028. 123 indexed citations
7.
Li, Jiaxin, Yang Yang, Meiyan Yang, et al.. (2021). Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells. Molecular Therapy — Nucleic Acids. 27. 349–362. 26 indexed citations
8.
Hao, Wenyan, Yueyue Fan, Mengyu Chen, et al.. (2021). Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery. Journal of Nanobiotechnology. 19(1). 378–378. 62 indexed citations
9.
Xu, Jing, et al.. (2020). Silencing of PRDX2 Inhibits the Proliferation and Invasion of Non‐Small Cell Lung Cancer Cells. BioMed Research International. 2020(1). 1276328–1276328. 12 indexed citations
10.
Kim, Raehyun, Peter J. Attayek, Yuli Wang, et al.. (2019). An in vitro intestinal platform with a self-sustaining oxygen gradient to study the human gut/microbiome interface. Biofabrication. 12(1). 15006–15006. 80 indexed citations
11.
Jiao, Qinlian, Yidan Ren, Qin Wang, et al.. (2019). Advances of immune checkpoints in colorectal cancer treatment. Biomedicine & Pharmacotherapy. 123. 109745–109745. 29 indexed citations
12.
Wang, Yuli, Pengju Zhang, Yunshan Wang, et al.. (2017). Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer. Cancer Research. 77(8). 1983–1996. 29 indexed citations
13.
Wang, Yuli. (2015). Research on the effects of Taxillus sutchuenensis volatile components in different host plants. 1 indexed citations
14.
Wang, Yuli. (2015). A Study on the Volatile Components of Taxillus sutchuenensis( Lecomte) Danser Living in Different Places of Guiyang. Traditional Chinese Medicine. 1 indexed citations
15.
Jin, Jingling, et al.. (2014). Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis. Pathology - Research and Practice. 210(10). 621–627. 18 indexed citations
16.
Wang, Yuli, Yueyong Liu, Jing Lü, et al.. (2013). Rapamycin inhibits FBXW7 loss-induced epithelial–mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells. Biochemical and Biophysical Research Communications. 434(2). 352–356. 67 indexed citations
17.
Wang, Yuli. (2009). Master Plan for Small Towns in Perspective of Urban and Rural Planning Act. Journal of Ningbo University.
18.
Feng, Yu-Mei, Xiaoqing Li, Baocun Sun, et al.. (2009). Evidence for a transcriptional signature of breast cancer. Breast Cancer Research and Treatment. 122(1). 65–75. 11 indexed citations
19.
Li, Jun, Yuli Wang, Yi Sun, & Theodore S. Lawrence. (2002). Wild-Type TP53 Inhibits G2-Phase Checkpoint Abrogation and Radiosensitization Induced by PD0166285, a WEE1 Kinase Inhibitor. Radiation Research. 157(3). 322–330. 48 indexed citations
20.
Wang, Yuli & Claudia Kent. (1995). Effects of Altered Phosphorylation Sites on the Properties of CTP:Phosphocholine Cytidylyltransferase. Journal of Biological Chemistry. 270(30). 17843–17849. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026